The "Post-Herpetic Neuralgia: The European Market and Competitive Landscape, 2018-2023" report has been added to ResearchAndMarkets.com's offering.
Post-Herpetic Neuralgia: The European Market and Competitive Landscape, 2018-2023, provides comprehensive insights into Post-Herpetic Neuralgia pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Post-Herpetic Neuralgia market size and drug sales. This research also provides insights into Post-Herpetic Neuralgia epidemiology and late stage pipeline.The research is classified into following sections - Post-Herpetic Neuralgia overview with definitions, symptoms, etiology, diagnosis, treatment options; Post-Herpetic Neuralgia pipeline insights covering late stage clinical trials pipeline; Post-Herpetic Neuralgia prevalence trends by countries; Post-Herpetic Neuralgia market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries - Germany, France, Italy, Spain, UK, Europe.
Key Topics Covered
1. Post-Herpetic Neuralgia: Disease Overview
2. Post-Herpetic Neuralgia Pipeline Insights
3. Post-Herpetic Neuralgia Epidemiology Analysis
4. Germany Post-Herpetic Neuralgia Market Insights
5. France Post-Herpetic Neuralgia Market Insights
6. Italy Post-Herpetic Neuralgia Market Insights
7. Spain Post-Herpetic Neuralgia Market Insights
8. UK Post-Herpetic Neuralgia Market Insights
9. Europe Post-Herpetic Neuralgia Market Insights
10. Research Methodology
For more information about this report visit https://www.researchandmarkets.com/research/bl5cfn/postherpetic?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20181211005439/en/
Contacts:
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Central
Nervous System Drugs
